DED pain origins are important to consider when determining treatment strategies for individuals with the disorder.

AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing a first-in-class therapeutic for peripheral neuropathic pain, ATX01, announced today the completion of the Last Patient Last ...

At NexGenEsis in Houston, Texas, doctors help their patients find relief from pain by turning on the body's healing power ...

These drugs can help by either blocking pain signals or changing how the brain processes pain. Topical Creams ... supplements ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing innovative therapies for neurologic and neuropsychiatric disorders, announced today that it ...

Current treatment options for neuropathic pain, including antidepressants, anticonvulsants, topical agents, and opioids, often provide limited relief and include significant side effects.